TRI's Dr. Steven R. Smith comments on advances in obesity treatment options


Emerging treatments in weight management were a major focus at the North American Menopause Society's 23rd Annual Meeting earlier this month. As new anti-obesity drugs enter the market, and metrics beyond traditional BMI and weight circumference (WC) measurements are becoming more commonplace, there is a greater understanding of the fundamental risks associated with obesity. "I think we're at a turning point in the medical practice regarding obesity therapy," said Dr. Steven Smith, scientific director of TRI. "Now we have tools in the tool kit other than [just] encouraging and using lifestyle management techniques in the office." Read the complete story.